Search results

666 results

Sorted by Relevance . Sort by Date

  1. Patient group directions

    Everything NICE has said on systems and processes to develop, authorise, use, and update patient group directions in an interactive flowchart

  2. Inadvertent perioperative hypothermia

    Everything NICE has said on preventing and managing inadvertent perioperative hypothermia in adults having surgery in an interactive flowchart

  3. Intravenous fluid therapy in hospital

    Everything NICE has said on managing intravenous fluid therapy in children, young people and adults in hospital in an interactive flowchart

  4. Renal cancer

    Everything NICE has said on renal (kidney) cancer in an interactive flowchart

  5. Harmful sexual behaviour among children and young people

    Everything NICE has said on harmful sexual behaviour among children and young people (under 18s or under 25s with special educational needs or a disability) in an interactive flowchart.

  6. Transition from children's to adults' services

    Everything NICE has said on the transition from children's to adults' services for young people in health or social care in an interactive flowchart

  7. Preterm labour and birth

    Everything NICE has said on the care of women in or at risk of preterm labour or having a planned preterm birth in an interactive flowchart

  8. Lung cancer

    Everything NICE has said on diagnosing and treating lung cancer in an interactive flowchart

  9. Postnatal care

    Everything NICE has said on the essential care that every woman and her baby should receive in the first 6–8 weeks after birth in an interactive flowchart

  10. Respiratory conditions

    Everything NICE has said on respiratory conditions in an interactive flowchart

  11. Generalised anxiety disorder

    Everything NICE has said on managing generalised anxiety disorder in adults in primary, secondary and community care in an interactive flowchart

  12. Aortic aneurysms

    Everything NICE has said on aortic aneurysms in an interactive flowchart

  13. Abdominal aortic aneurysm

    Everything NICE has said on diagnosing and managing abdominal aortic aneurysm in an interactive flowchart

  14. Head injury

    Everything NICE has said on triage, assessment, investigation and management of head injury in infants, children and adults in an interactive flowchart

  15. Heavy menstrual bleeding

    Everything NICE has said on assessing and managing heavy menstrual bleeding in an interactive flowchart

  16. Dementia

    Everything NICE has said on assessment, management and support for people living with dementia and Alzheimer's disease and their carers in an interactive flowchart

  17. Stroke

    Everything NICE has said on preventing, diagnosing and managing stroke and transient ischaemic attack (TIA) in people over 16 in an interactive flowchart

  18. Pressure ulcers

    Everything NICE has said on preventing and managing pressure ulcers in all age groups in primary care and community settings in an interactive flowchart

  19. Skin conditions

    Everything NICE has said on managing skin conditions and skin damage in an interactive flowchart

  20. Foot care for people with diabetes

    Everything NICE has said on preventing and managing foot problems in children, young people and adults with type 1 or 2 diabetes in an interactive flowchart

  21. Suspected cancer recognition and referral

    Everything NICE has said on suspected cancer, recognition and selection for referral or investigation in primary care in an interactive flowchart

  22. Bedwetting in children and young people

    Everything NICE has said on assessing and managing bedwetting (nocturnal enuresis) in children and young people under 19 in an interactive flowchart

  23. Influenza

    Everything NICE has said on influenza in an interactive flowchart

  24. Medicines optimisation in chronic pain (KTT21)

    This document summarises the evidence base on medicines optimisation in chronic pain . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  25. Chemotherapy dose standardisation (KTT22)

    This document summarises the evidence base on chemotherapy dose standardisation . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  26. Shared decision making (KTT23)

    This document summarises the evidence base on shared decision making . It is a key therapeutic topic that has been identified to support Medicines Optimisation. It is not formal NICE guidance .

  27. Lipid-modifying drugs (KTT3)

    This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on lipid-modifying drugs. It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  28. Asthma: medicines safety priorities (KTT5)

    This document summarises the evidence base on asthma: medicines safety priorities . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  29. Wound care products (KTT14)

    This document summarises the evidence base on wound care products . It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .

  30. Biosimilar medicines (KTT15)

    The key therapeutic topic biosimilar medicines has been retired from the 2019 update of medicines optimisation: key therapeutic topics. The version published in 2018 is available here for information but it has not been updated since February 2018. Like all the other key therapeutic topics it is not formal NICE guidance .

  31. Anticoagulants, including direct-acting oral anticoagulants (DOACs) (KTT16)

    This key therapeutic topic has been reincluded in the September 2019 update of medicines optimisation: key therapeutic topics. This document summarises the evidence base on anticoagulants , including direct-acting oral anticoagulants (DOACs). It is a key therapeutic topic that has been identified to support medicines optimisation. It is not formal NICE guidance .